Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RAB9A | P51151 | 6/20 | 0.48 |
| ▸ | MEN1 | O00255 | 6/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.48 |
| ▸ | NPC1 | O15118 | 5/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.48 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.48 |
| ▸ | TP53 | P04637 | 2/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.48 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | KMO | O15229 | 1/20 | 0.40 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.38 |
| ▸ | ACHE | P22303 | 2/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | BCHE | P06276 | 1/20 | 0.36 |
| ▸ | PIK3R1 | P27986 | 1/20 | 0.36 |
| ▸ | PIK3CA | P42336 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1188116 | 0.78 | MEN1 (0.50) | RAB9AMEN1KMT2ANPC1ALDH1A1 | |
| SCHEMBL28481167 | 0.78 | RAB9A (0.46) | RAB9AMEN1KMT2ANPC1ALDH1A1 | |
| SCHEMBL8590923 | 0.78 | KMO (0.40) | KMOPPARAMETAP2APP | |
| SCHEMBL19356875 | 0.78 | KMO (0.40) | KMOPPARA | |
| SCHEMBL3398203 | 0.78 | KMO (0.47) | RAB9AMEN1KMT2ANPC1MAPT | |
| SCHEMBL2740475 | 0.78 | NPC1 (0.40) | RAB9AMEN1KMT2ANPC1HSD17B10 | |
| SCHEMBL6854121 | 0.78 | NPC1 (0.43) | RAB9AMEN1KMT2ANPC1ALDH1A1 | |
| SCHEMBL16907809 | 0.78 | NR1H4 (0.44) | RAB9AMEN1KMT2ANPC1ALDH1A1 | |
| SCHEMBL25447823 | 0.78 | ADRB2 (0.55) | NPC1ALDH1A1HPGDHSD17B10SMN1; SMN2 | |
| SCHEMBL14441201 | 0.78 | NOTUM (0.44) | RAB9ANPC1MAPTHPGDSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-121342814-A | Preparation method of antiviral drug amoenavir | 安徽峆一药业股份有限公司 | 2026-01-16 | — | — | CN | disclosed |
| CN-120820639-A | Method for separating and detecting amotene Wei Qishi material 4- (1, 2, 4-oxadiazole-3-yl) aniline and impurities thereof | 重庆凯林制药有限公司 | 2025-10-21 | — | — | CN | disclosed |
| CN-120820639-A | Method for separating and detecting amotene Wei Qishi material 4- (1, 2, 4-oxadiazole-3-yl) aniline and impurities thereof | 重庆凯林制药有限公司 | 2025-10-21 | — | — | CN | disclosed |
| CN-113149928-A | Fluoro-1, 2, 4-oxadiazole-containing compound and preparation method and application thereof | 青海省人民医院 | 2021-07-23 | — | — | CN | disclosed |
| WO-2020038812-A1 | NEW PROCESS FOR THE PREPARATION OF AMENAMEVIR | RIJKSUNIVERSITEIT GRONINGEN (NL) | 2020-02-27 | — | — | WO | disclosed |
| WO-2020038812-A1 | NEW PROCESS FOR THE PREPARATION OF AMENAMEVIR | RIJKSUNIVERSITEIT GRONINGEN (NL) | 2020-02-27 | — | — | WO | disclosed |
| EP-2978756-B1 | SUBSTITUTED OXOPYRIDINE DERIVATIVES AND THEIR USE IN THE TREATMENT OF CARDIOVASCULAR DISEASES | Bayer Pharma AG (DE) | 2019-03-27 | — | — | EP | disclosed |
| US-10183932-B2 | Substituted oxopyridine derivatives and use thereof cardiovascular disorders | BAYER PHARMA AKTIENGESELLSCHAFT (DE) | 2019-01-22 | — | — | US | disclosed |
| EP-2593425-B1 | THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE | AGIOS PHARMACEUTICALS INC (US) | 2018-10-17 | — | — | EP | disclosed |
| CN-108164513-A | Substituted oxo pyridine derivative and its purposes in terms of cardiovascular disorder is treated | 拜耳制药股份公司 | 2018-06-15 | — | — | CN | disclosed |
| US-20090239810-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-09-24 | — | — | US | disclosed |
| US-20090239810-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-09-24 | — | — | US | disclosed |
| WO-2009117676-A2 | NOVEL PIPERIDINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-09-24 | — | — | WO | disclosed |
| WO-2009117659-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-COA DESATURASE | FOREST LABORATORIES HOLDINGS LIMITED (BM) | 2009-09-24 | — | — | WO | disclosed |
| US-20060276433-A1 | Hydrazone derivative | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-12-07 | — | — | US | disclosed |
| EP-1612204-A1 | HYDRAZONE DERIVATIVE | DAIICHI PHARMACEUTICAL CO., LTD. (JP) | 2006-01-04 | — | — | EP | disclosed |
| US-20050107456-A1 | Substituted pyrazolines for use as pesticides | BAYER CROPSCIENCE AG (DE) | 2005-05-19 | — | — | US | disclosed |
| EP-1467971-A1 | SUBSTITUTED PYRAZOLINES FOR USE AS PESTICIDES | Bayer CropScience AG (DE) | 2004-10-20 | — | — | EP | disclosed |
| WO-2003059887-A1 | SUBSTITUTED PYRAZOLINES FOR USE AS PESTICIDES | BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) | 2003-07-24 | — | — | WO | disclosed |
| US-4003909-A | [(1,2,4-Oxadiazol-3-yl)phenyl]carbamic or thiocarbamic acid esters | E. R. SQUIBB & SONS, INC. (US) | 1977-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10183932-B2 | Substituted oxopyridine derivatives and use thereof cardiovascular disorders | OGFOD1, VASP, PNPO | RAB9A 1862/4885MEN1 2573/4885KMT2A 3545/4885 |
| US-20090239810-A1 | NOVEL PIPERAZINE DERIVATIVES AS INHIBITORS OF STEAROYL-CoA DESATURASE | SCD, SCD5, FADS2 | RAB9A 3858/4885MEN1 4884/4885KMT2A 1352/4885 |
| US-20050107456-A1 | Substituted pyrazolines for use as pesticides | DDT, ACHE, CHRM1 | RAB9A 353/4885MEN1 2809/4885KMT2A 3248/4885 |
| US-20060276433-A1 | Hydrazone derivative | APP, PRNP, HTT | RAB9A 3127/4885MEN1 3031/4885KMT2A 3533/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.